{"id":537693,"date":"2026-07-22T00:00:10","date_gmt":"2026-07-22T00:00:10","guid":{"rendered":"https:\/\/www.newsbeep.com\/nz\/537693\/"},"modified":"2026-07-22T00:00:10","modified_gmt":"2026-07-22T00:00:10","slug":"whats-at-stake-as-beijing-beats-global-peers-with-first-approval-of-novel-therapy","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/nz\/537693\/","title":{"rendered":"What\u2019s at stake as Beijing beats global peers with first approval of novel therapy"},"content":{"rendered":"<p>China\u2019s drug regulator has for the first time approved a novel, globally trialled medicine ahead of authorities in the United States, Japan and Europe, marking a \u201chistoric breakthrough\u201d as the country doubles down on <a target=\"_self\" class=\"e1yy41x40 ef9u0v01 css-1ankfgb ecgc78b0\" href=\"https:\/\/www.scmp.com\/business\/china-business\/article\/3358830\/funding-option-royalties-giant-opens-hong-kong-base-mainland-china-biotech-deals-surge?module=inline&amp;pgtype=article\" title=\"\" data-qa=\"BaseLink-renderAnchor-StyledAnchor\" rel=\"nofollow noopener\">biopharmaceuticals as one of its growth engines<\/a>.The drug was filed for market approval in multiple countries, and \u201cChina was the first in the world to approve it\u201d, Xu Xiaoqiang, head of chemical drugs registration at the <a target=\"_self\" class=\"e1yy41x40 ef9u0v01 css-1ankfgb ecgc78b0\" href=\"https:\/\/www.scmp.com\/tech\/big-tech\/article\/3360684\/china-completes-worlds-first-commercial-brain-computer-interface-implant?module=inline&amp;pgtype=article\" title=\"\" data-qa=\"BaseLink-renderAnchor-StyledAnchor\" rel=\"nofollow noopener\">National Medical Products Administration<\/a> (NMPA), told state broadcaster CCTV on Tuesday.\u201cIt marks a historic breakthrough for China\u201d in globally developed, first-in-class drug innovation, Xu said, noting that Chinese patients had been included from the outset in <a target=\"_self\" class=\"e1yy41x40 ef9u0v01 css-1ankfgb ecgc78b0\" href=\"https:\/\/www.scmp.com\/business\/china-business\/article\/3358082\/chinas-biotech-surge-sparks-us-security-concerns-drug-trials-break-records-2025?module=inline&amp;pgtype=article\" title=\"\" data-qa=\"BaseLink-renderAnchor-StyledAnchor\" rel=\"nofollow noopener\">international clinical trials<\/a>, enabling approval ahead of anywhere else.<\/p>\n<p datatype=\"p\" data-qa=\"Component-Component\" class=\"e8zc9q40 css-1c6uqr6 ec74h0k1\">The NMPA gave the green light for commercial sales of a rare-disease therapy for narcolepsy type 1 in people aged 16 and older, state media reported.<\/p>\n<p datatype=\"p\" data-qa=\"Component-Component\" class=\"e8zc9q40 css-1c6uqr6 ec74h0k1\">The drug was not named, but reports said it had won fast-track designations in the US and orphan-drug designation in Japan and the European Union. Orphan-drug status means a therapy for a rare disease gets government incentives like tax breaks and exclusive rights to make development viable.<\/p>\n<p datatype=\"p\" data-qa=\"Component-Component\" class=\"e8zc9q40 css-1c6uqr6 ec74h0k1\">Narcolepsy type 1 is a lifelong brain condition that makes people intensely sleepy during the day and causes them to fall asleep without warning. For many sufferers, it also causes them to suddenly lose control of their muscles when they feel strong emotions, like laughing, being surprised, or getting angry.<\/p>\n","protected":false},"excerpt":{"rendered":"China\u2019s drug regulator has for the first time approved a novel, globally trialled medicine ahead of authorities in&hellip;\n","protected":false},"author":2,"featured_media":537694,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[21181,607,2024,134,1759,264813,264811,111,139,129557,69,264809,264810,3040,264812],"class_list":["post-537693","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-cctv","tag-china","tag-europe","tag-health","tag-japan","tag-narcolepsy-type","tag-national-medical-products-administration","tag-new-zealand","tag-newzealand","tag-nmpa","tag-nz","tag-takeda","tag-therapeutic-innovation-regulatory-science","tag-us","tag-xu-xiaoqiang"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/537693","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/comments?post=537693"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/posts\/537693\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media\/537694"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/media?parent=537693"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/categories?post=537693"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/nz\/wp-json\/wp\/v2\/tags?post=537693"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}